Table 2:
S/No. | Study (reference) | Patient no. | Laser parameters | Treatment sittings | Follow-up | Outcome | Adverse effects |
---|---|---|---|---|---|---|---|
1 | Downs et al.[26] | 1 | Diode 14 J/cm2; 50ms, 6 mm | 4 | None | Decreased erythema and tenderness | Pain during treatment |
2 | Highton et al.[25] | 17 | IPL (420nm); 7–10 J/ cm2, 30–50 ms | 8 | 12 months | Significant improvement of treated site compared to control and maintained in F/U period | Erythema posttreatment |
3 | Mahmoud et al.[28] | 17 | Nd:YAG; 40–50 J/cm2, 20ms, 10mm (skin types I–III); 25–35 J/ cm2, 35ms, 10mm (skin types IV–VI) | 4 | 2 months | Progressive reduction in disease activity; remission maintained in follow-up period | 40% patients experienced periprocedural pain |
4 | Tierney et al.[24] | 17 | Nd:YAG; 40–50 J/cm2, 20ms, 10mm (skin types I–III); 25–35 J/ cm2, 35ms, 10mm (skin types IV–VI) | 3 | 1 month | Statistically significant improvement in HS severity of 65.3% averaged over all body sites treated (LHR + topical antibiotics) compared to control (topical antibiotics) at 3 months | Initial worsening of inflammation |
5 | Koch et al.[23] | 1 | Alexandrite; 15–22 J/ cm2, 20ms, 15 mm | 6 | 10 months | Excellent response | — |
6 | Jain et al.[29] | 4 | Nd:YAG+ CO2 laser | 4–5 | 3 years | None showed any recurrence | — |
7 | Xu et al.[27] | 20 | Nd:YAG | 2 | 2 months | Significant improvement of treated site compared to control at 2 months; clinicopathologic correlation between disease activity and histological characteristics following laser treatment was also noted | Initial worsening of inflammation |
HS = hidradenitis suppurativa; IPL = intense pulse light; LHR = laser hair removal; Nd:YAG = neodymium:yttrium aluminum garnet